UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders

1. De Lago, E.
2. Fernández-Ruiz, J.
3. Ortega-Gutiérrez, S.
4. Cabranes, A.
5. Pryce, G.
6. Baker, D.
7. López-Rodríguez, M.
8. Ramos, J.A.